The Impact of Additional Prognostic Factors on Survival and their Relationship with the Anatomical Extent of Disease Expressed by the 6th Edition of the TNM Classification of Malignant Tumors and the Proposals for the 7th Edition-Reference-Cited by-同舟云学术

The Impact of Additional Prognostic Factors on Survival and their Relationship with the Anatomical Extent of Disease Expressed by the 6th Edition of the TNM Classification of Malignant Tumors and the Proposals for the 7th Edition

Published:2008-05 Issue:5 Volume:3 Page:457-466
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Sculier Jean-Paul,Chansky Kari,Crowley John J.,Van Meerbeeck Jan,Goldstraw Peter

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference38 articles.

1. The International Association for the Study of Lung Cancer international staging project on lung cancer;Goldstraw;J Thorac Oncol,2006

2. The IASLC Lung Cancer Staging Project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer;Rami-Porta;J Thorac Oncol,2007

3. The IASLC Lung Cancer Staging Project: proposals for the revision of the N descriptors in the forthcoming seventh edition of the TNM classification for lung cancer;Rusch;J Thorac Oncol,2007

4. The IASLC Lung Cancer Staging Project: proposals for revision of the M descriptors in the forthcoming (seventh) edition of the TNM classification of lung cancer;Postmus;J Thorac Oncol,2007

5. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours;Goldstraw;J Thorac Oncol,2007

Cited by 308 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapy combined with antiangiogenic therapy as third‐ or further‐line therapy for stage IV non‐small cell lung cancer patients with ECOG performance status 2: A retrospective study;Cancer Medicine;2024-06

2. Clinical Significance of Preserving Pulmonary Function After Lung Resection in Early-Stage Non–Small-Cell Lung Cancer;Clinical Lung Cancer;2024-06

3. Construction of a Nomogram to Predict the Progression Free Survival in Patients With Lung Cancer;2024-05-08

4. Brief report: Carboplatin, weekly Paclitaxel and Pembrolizumab in elderly patients for advanced Non-Small Cell Lung Cancer with PD-L1<50%: real-world data.;Clinical Lung Cancer;2024-05

5. Does FDG PET-Based Radiomics Have an Added Value for Prediction of Overall Survival in Non-Small Cell Lung Cancer?;Journal of Clinical Medicine;2024-04-29